Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in taiwan

Journal of Clinical Psychopharmacology

Volumn 30, Issue 3, 2010, Pages 230-234

  Hsu, Wen Yu ^a   Huang, Si Sheng ^a,b   Lee, Bo Shyan ^a   Chiu, Nan Ying ^a,c  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

Agitation; Haloperidol; Injection; Olanzapine; Orally; Risperidone

Indexed keywords

HALOPERIDOL; OLANZAPINE; RISPERIDONE;

ADULT; AGED; AGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; EARLY INTERVENTION; EMERGENCY CARE; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SINGLE BLIND PROCEDURE; TABLET DISINTEGRATION; TAIWAN; TREATMENT DURATION;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; BENZODIAZEPINES; DISEASE MANAGEMENT; FEMALE; HALOPERIDOL; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; PHARMACEUTICAL SOLUTIONS; PROSPECTIVE STUDIES; PSYCHIATRIC DEPARTMENT, HOSPITAL; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS; RISPERIDONE; SOLUBILITY; TABLETS; TAIWAN; TREATMENT OUTCOME;

EID: 77952404770     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181db8715     Document Type: Article

References (16)

1. Grassi L, Peron L, Marangoni C, et al. Characteristics of violent behaviour in acute psychiatric in-patients: a 5-year Italian study. Acta Psychiatr Scand. 2001;104:273-279.
2. Lindenmayer JP. The pathophysiology of agitation. J Clin Psychiatry. 2000;61(suppl 14):5-10.
3. Battaglia J. Pharmacological management of acute agitation. Drugs. 2005;65:1207-1222.
4. Battaglia J, Moss S, Rush J, et al. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med. 1997;15:335-340.
5. Salzman C, Green AI, Rodriguez-Villa F, et al. Benzodiazepines combined with neuroleptics for management of severe disruptive behavior. Psychosomatics. 1986;27:17-22.
6. Buckley PF. The role of typical and atypical antipsychotic medications in the management of agitation and aggression. J Clin Psychiatry. 1999;60(suppl 10):52-60.
7. Castle DJ, Udristoiu T, Kim CY, et al. Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation. World J Biol Psychiatry. 2009;10:43-53.
8. Villari V, Rocca P, Fonzo V, et al. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:405-413.
9. Kinon BJ, Stauffer VL, Kollack-Walker S, et al. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. J Clin Psychopharmacol. 2008;28: 601-607.
10. Lambert M, Huber CG, Naber D, et al. Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder. Pharmacopsychiatry. 2008;41:182-189.
11. Pascual JC, Perez V, Martin JL, et al. Olanzapine orally-disintegrating tablet in severe psychotic agitation: a naturalistic study. Actas Esp Psiquiatr. 2007;35:47-51.
12. Hatta K, Kawabata T, Yoshida K, et al. Olanzapine orally disintegrating tablet vs. risperidone oral solution in the treatment of acutely agitated psychotic patients. Gen Hosp Psychiatry. 2008;30:367-371.
13. Wright P, Birkett M, David SR, et al. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry. 2001;158:1149-1151.
14. Chue P, Jones B, Taylor CC, et al. Dissolution profile, tolerability, and acceptability of the orally disintegrating olanzapine tablet in patients with schizophrenia. Can J Psychiatry. 2002;47:771-774.
15. Reeves RR, Torres RA. Onset of action of orally disintegrating olanzapine versus conventional olanzapine. South Med J. 2004;97:212.
16. Markowitz JS, DeVane CL, Malcolm RJ, et al. Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers. J Clin Pharmacol. 2006;46:164-171.